| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Drosophila melanogaster |
Drosophila melanogaster |
GI |
nan |
None |
10.1016/j.bmc.2011.09.059 |
| Homo sapiens |
786-0 |
IC50 |
2250.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
A2780 |
IC50 |
3800.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
A-375 |
IC50 |
4.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
A-431 |
IC50 |
4100.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
A549 |
GI50 |
5000.0 |
nM |
10.1021/jm300605m |
| Homo sapiens |
A549 |
GI50 |
10000.0 |
nM |
10.1016/j.bmc.2009.09.021 |
| Homo sapiens |
A549 |
GI50 |
10000.0 |
nM |
10.1016/j.bmc.2011.10.014 |
| Homo sapiens |
A549 |
IC50 |
32.0 |
nM |
10.1016/j.ejmech.2019.01.017 |
| Homo sapiens |
A549 |
IC50 |
800.0 |
nM |
10.1021/acs.jnatprod.5b00877 |
| Homo sapiens |
A549 |
IC50 |
1557.0 |
nM |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
A549 |
IC50 |
1880.93 |
nM |
10.1016/j.bmc.2018.08.008 |
| Homo sapiens |
A549 |
IC50 |
2000.0 |
nM |
10.1016/j.ejmech.2022.114660 |
| Homo sapiens |
A549 |
IC50 |
4610.0 |
nM |
10.1016/j.bmc.2010.03.039 |
| Homo sapiens |
A549 |
IC50 |
5237.6 |
nM |
10.1016/j.ejmech.2019.111971 |
| Homo sapiens |
A549 |
IC50 |
6400.0 |
nM |
10.1021/jm100387d |
| Homo sapiens |
A549 |
IC50 |
6528.0 |
nM |
10.1016/j.bmc.2007.10.046 |
| Homo sapiens |
A549 |
IC50 |
8300.0 |
nM |
10.1016/j.bmcl.2017.02.066 |
| Homo sapiens |
A549 |
IC50 |
8300.0 |
nM |
10.1016/j.bmcl.2017.09.012 |
| Homo sapiens |
A549 |
IC50 |
8310.0 |
nM |
10.1016/j.bmcl.2017.07.078 |
| Homo sapiens |
A549 |
IC50 |
9140.0 |
nM |
10.1016/j.ejmech.2021.113639 |
| Homo sapiens |
A549 |
IC50 |
9480.0 |
nM |
10.1016/j.bmcl.2012.10.002 |
| Homo sapiens |
A549 |
IC50 |
9480.0 |
nM |
10.1016/j.ejmech.2016.02.070 |
| Homo sapiens |
A549 |
IC50 |
9500.0 |
nM |
10.1021/jm5003588 |
| Homo sapiens |
A549 |
IC50 |
16530.0 |
nM |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
A549 |
IC50 |
19710.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
A549 |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2017.03.039 |
| Homo sapiens |
A549 |
IC50 |
20100.0 |
nM |
10.1021/acs.jmedchem.5b00910 |
| Homo sapiens |
A549 |
IC50 |
26690.0 |
nM |
10.1016/j.bmcl.2021.128146 |
| Homo sapiens |
A549 |
Inhibition |
91.8 |
% |
10.1021/acs.jnatprod.6b00783 |
| Homo sapiens |
A549 |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
A549 |
T/C |
0.4 |
None |
10.1021/acsmedchemlett.2c00442 |
| Homo sapiens |
A549 |
TGI |
50.0 |
% |
10.1021/jm301788a |
| Homo sapiens |
A549 |
TGI |
51.0 |
% |
10.1016/j.bmc.2010.03.039 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
1827.0 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
50.5 |
nM |
10.1021/jm701253t |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
Activity |
0.129 |
nM/mg*min |
10.1016/s0960-894x(98)00039-0 |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
Km |
1453000.0 |
nM |
10.1016/j.bmc.2009.10.052 |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
pKm |
2.84 |
None |
10.1016/j.bmc.2009.10.052 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
3171.0 |
nM |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
461.0 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1124/mol.63.1.65 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
BGC-823 |
T/C |
5.48 |
% |
10.1016/j.ejmech.2016.11.013 |
| Homo sapiens |
BGC-823 |
TGI |
94.1 |
% |
10.1016/j.ejmech.2016.11.013 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
BT-483 |
Activity |
nan |
None |
10.1016/j.ejmech.2013.01.011 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
101.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
CAPAN-1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
CAPAN-1 |
IC50 |
1121.0 |
nM |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
CAPAN-1 |
IC50 |
1500.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
CAPAN-1 |
T/C |
7.92 |
% |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCD-18Co |
IC50 |
18500.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
CCD-841CoN |
IC50 |
13200.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
CCD-841CoN |
IC50 |
90250.0 |
nM |
10.1016/j.bmcl.2021.128146 |
| Homo sapiens |
CCRF-CEM |
IC50 |
nan |
None |
10.1016/j.ejmech.2014.02.018 |
| Homo sapiens |
CCRF-CEM |
Ratio IC50 |
nan |
None |
10.1016/j.ejmech.2014.02.018 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
COLO 205 |
Activity |
162.0 |
% |
10.1021/acsmedchemlett.9b00568 |
| Homo sapiens |
COLO 205 |
TGI |
75.0 |
% |
10.1021/acsmedchemlett.9b00568 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
24000.0 |
nM |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Kinact |
0.06 |
min-1 |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 3A4 |
Log 1/Km |
-1.265 |
None |
10.1016/j.bmcl.2005.06.015 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DG-75 |
Activity |
0.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
DG-75 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
DNA topoisomerase I |
CC50 |
100000.0 |
nM |
10.1021/jm00105a017 |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1016/j.bmcl.2014.01.039 |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1016/j.ejmech.2020.112509 |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1021/jm301788a |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1021/jm5003588 |
| Homo sapiens |
DNA topoisomerase I |
REC |
25.0 |
None |
10.1021/jm020498a |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
DU-145 |
IC50 |
200.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
DU-145 |
IC50 |
2800.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
DU-145 |
IC50 |
9300.0 |
nM |
10.1016/j.bmcl.2012.10.002 |
| Homo sapiens |
DU-145 |
IC50 |
9300.0 |
nM |
10.1021/jm5003588 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
H69AR |
IC50 |
250.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
HCT-116 |
Activity |
0.256 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HCT-116 |
Activity |
1.51 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HCT-116 |
Activity |
6.15 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HCT-116 |
Activity |
35.4 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HCT-116 |
Activity |
92.5 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HCT-116 |
Activity |
nan |
None |
10.1021/jm201702g |
| Homo sapiens |
HCT-116 |
GI |
85.0 |
% |
10.1016/j.bmc.2011.08.068 |
| Homo sapiens |
HCT-116 |
GI50 |
7100.0 |
nM |
10.1021/jm300605m |
| Homo sapiens |
HCT-116 |
IC50 |
4.4 |
nM |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
HCT-116 |
IC50 |
498.0 |
nM |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
HCT-116 |
IC50 |
600.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
HCT-116 |
IC50 |
1633.47 |
nM |
10.1016/j.bmc.2018.08.008 |
| Homo sapiens |
HCT-116 |
IC50 |
6300.0 |
nM |
10.1016/j.bmcl.2017.03.039 |
| Homo sapiens |
HCT-116 |
IC50 |
9700.0 |
nM |
10.1016/j.ejmech.2020.112599 |
| Homo sapiens |
HCT-116 |
IC50 |
12030.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
HCT-116 |
IC50 |
14220.0 |
nM |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HCT-116 |
IC50 |
18600.0 |
nM |
10.1021/acs.jmedchem.5b00910 |
| Homo sapiens |
HCT-116 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2020.112509 |
| Homo sapiens |
HCT-116 |
ID50 |
540.0 |
nM |
10.1016/s0960-894x(02)00153-1 |
| Homo sapiens |
HCT-116 |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
HCT-116/VM46 |
ID50 |
220.0 |
nM |
10.1016/s0960-894x(02)00153-1 |
| Homo sapiens |
HCT-15 |
IC50 |
2700.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
HEK293 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2020.112509 |
| Homo sapiens |
HEK-293T |
IC50 |
19830.0 |
nM |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
HeLa |
GI50 |
1000.0 |
nM |
10.1016/j.bmc.2007.03.067 |
| Homo sapiens |
HeLa |
IC50 |
32.0 |
nM |
10.1016/j.ejmech.2019.01.017 |
| Homo sapiens |
HeLa |
IC50 |
5800.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
HepG2 |
Activity |
0.47 |
g |
10.1016/j.ejmech.2018.07.028 |
| Homo sapiens |
HepG2 |
GI50 |
5940.0 |
nM |
10.1016/j.bmc.2009.09.021 |
| Homo sapiens |
HepG2 |
GI50 |
5940.0 |
nM |
10.1016/j.bmc.2011.10.014 |
| Homo sapiens |
HepG2 |
IC50 |
900.0 |
nM |
10.1021/acs.jnatprod.5b00877 |
| Homo sapiens |
HepG2 |
IC50 |
4000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
HepG2 |
IC50 |
34070.0 |
nM |
10.1016/j.ejmech.2022.114660 |
| Homo sapiens |
HepG2 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2020.112509 |
| Homo sapiens |
HepG2 |
IC50 |
nan |
None |
10.1016/j.bmc.2021.116360 |
| Homo sapiens |
HepG2 |
IC50 relative |
10100.0 |
nM |
10.6019/EOS300108 |
| Homo sapiens |
HepG2 |
Inhibition |
98.9 |
% |
10.1021/acs.jnatprod.6b00783 |
| Homo sapiens |
HepG2 |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
HepG2 |
T/C |
35.08 |
% |
10.1016/j.ejmech.2018.07.028 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.68 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-2.26 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
IC50 |
32.0 |
nM |
10.1016/j.ejmech.2019.01.017 |
| Homo sapiens |
HL-60 |
IC50 |
4240.0 |
nM |
10.1016/j.bmcl.2021.128146 |
| Homo sapiens |
HL-60 |
IC50 |
nan |
None |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
CL |
7.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
2.24 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
k_elim |
0.101 |
hr-1 |
10.1124/dmd.110.035451 |
| Homo sapiens |
Homo sapiens |
k_elim |
0.12 |
hr-1 |
10.1124/dmd.110.035451 |
| Homo sapiens |
Homo sapiens |
MRT |
9.1 |
hr |
10.1016/j.bmcl.2016.12.085 |
| Homo sapiens |
Homo sapiens |
T1/2 |
5.2 |
hr |
10.1016/j.bmcl.2016.12.085 |
| Homo sapiens |
HT-29 |
Activity |
18.3 |
% |
10.1021/jm301217c |
| Homo sapiens |
HT-29 |
Activity |
123.0 |
mm3 |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
Activity |
152.0 |
mm3 |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
Activity |
223.0 |
mm3 |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
Activity |
250.0 |
% |
10.1016/j.bmcl.2007.12.046 |
| Homo sapiens |
HT-29 |
Activity |
266.0 |
% |
10.1016/j.bmcl.2007.12.046 |
| Homo sapiens |
HT-29 |
Activity |
298.0 |
% |
10.1016/j.bmcl.2007.12.046 |
| Homo sapiens |
HT-29 |
Activity |
316.0 |
mm3 |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
Activity |
387.0 |
mm3 |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
Activity |
538.0 |
mm3 |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
Efficacy |
71.0 |
% |
10.1021/acs.jnatprod.5b00072 |
| Homo sapiens |
HT-29 |
GI |
22.85 |
% |
10.1016/j.ejmech.2018.10.037 |
| Homo sapiens |
HT-29 |
GI |
37.35 |
% |
10.1016/j.ejmech.2018.10.037 |
| Homo sapiens |
HT-29 |
GI |
54.71 |
% |
10.1016/j.ejmech.2018.10.037 |
| Homo sapiens |
HT-29 |
GI |
59.29 |
% |
10.1016/j.ejmech.2018.10.037 |
| Homo sapiens |
HT-29 |
IC50 |
220.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
HT-29 |
IC50 |
1900.0 |
nM |
10.1021/acs.jnatprod.5b00072 |
| Homo sapiens |
HT-29 |
IC50 |
3550.0 |
nM |
10.1016/j.ejmech.2019.111807 |
| Homo sapiens |
HT-29 |
IC50 |
3960.0 |
nM |
10.1016/j.ejmech.2019.111807 |
| Homo sapiens |
HT-29 |
IC50 |
4800.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
HT-29 |
IC50 |
6850.0 |
nM |
10.1016/j.bmcl.2021.128146 |
| Homo sapiens |
HT-29 |
IC50 |
9500.0 |
nM |
10.1016/j.ejmech.2020.112599 |
| Homo sapiens |
HT-29 |
IC50 |
82750.0 |
nM |
10.1016/j.ejmech.2014.02.018 |
| Homo sapiens |
HT-29 |
Ratio IC50 |
1.12 |
None |
10.1016/j.ejmech.2019.111807 |
| Homo sapiens |
HT-29 |
T/C |
42.22 |
% |
10.1016/j.bmc.2015.03.031 |
| Homo sapiens |
HT-29 |
TGI |
nan |
None |
10.1021/jm301788a |
| Homo sapiens |
HT-29 |
TIME |
153.6 |
hr |
10.1021/jm3012933 |
| Homo sapiens |
IGROV-1 |
IC50 |
30.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
JeKo-1 |
Activity |
48.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
JeKo-1 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
K562 |
GI50 |
1900.0 |
nM |
10.1021/np500552a |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KB |
IC50 |
6314.3 |
nM |
10.1016/j.ejmech.2019.111971 |
| Homo sapiens |
KB |
IC50 |
7990.0 |
nM |
10.1016/j.bmcl.2017.02.066 |
| Homo sapiens |
KB |
IC50 |
7990.0 |
nM |
10.1016/j.bmcl.2017.07.078 |
| Homo sapiens |
KB |
IC50 |
7990.0 |
nM |
10.1016/j.bmcl.2017.09.012 |
| Homo sapiens |
KB |
IC50 |
9800.0 |
nM |
10.1021/jm5003588 |
| Homo sapiens |
KB |
IC50 |
9828.0 |
nM |
10.1016/j.ejmech.2016.02.070 |
| Homo sapiens |
KB |
IC50 |
9830.0 |
nM |
10.1016/j.bmcl.2012.10.002 |
| Homo sapiens |
KM-H2 |
Activity |
12.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
KM-H2 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
L02 |
IC50 |
1305.0 |
nM |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
L02 |
IC50 |
22220.0 |
nM |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
L-428 |
Activity |
0.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
L-428 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
LNCaP |
IC50 |
9.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
LoVo |
IC50 |
4990.0 |
nM |
10.1016/j.bmc.2010.03.039 |
| Homo sapiens |
LoVo |
IC50 |
8800.0 |
nM |
10.1021/jm100387d |
| Homo sapiens |
LoVo |
IC50 |
9015.0 |
nM |
10.1016/j.bmc.2007.10.046 |
| Homo sapiens |
LS174T |
IC50 |
700.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
LS174T |
IC50 |
1160.0 |
nM |
10.1016/j.bmc.2008.05.022 |
| Homo sapiens |
Malme-3M |
IC50 |
200.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
6060.0 |
nM |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
CI |
0.16 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
0.18 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
0.78 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
0.97 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
1.16 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
1.3 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
1.4 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
1.49 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
1.6 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
2.1 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
CI |
nan |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
Efficacy |
82.0 |
% |
10.1021/acs.jnatprod.5b00072 |
| Homo sapiens |
MCF7 |
GI50 |
1000.0 |
nM |
10.1016/j.bmc.2007.03.067 |
| Homo sapiens |
MCF7 |
GI50 |
10000.0 |
nM |
10.1016/j.bmc.2011.10.014 |
| Homo sapiens |
MCF7 |
IC50 |
160.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
210.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
500.0 |
nM |
10.1021/acs.jnatprod.5b00877 |
| Homo sapiens |
MCF7 |
IC50 |
800.0 |
nM |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
MCF7 |
IC50 |
800.0 |
nM |
10.1021/acs.jnatprod.9b00580 |
| Homo sapiens |
MCF7 |
IC50 |
900.0 |
nM |
10.1021/acs.jnatprod.5b00072 |
| Homo sapiens |
MCF7 |
IC50 |
1680.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
1880.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
1980.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
2420.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
11300.0 |
nM |
10.1016/j.bmcl.2017.02.066 |
| Homo sapiens |
MCF7 |
IC50 |
11300.0 |
nM |
10.1016/j.bmcl.2017.09.012 |
| Homo sapiens |
MCF7 |
IC50 |
11320.0 |
nM |
10.1016/j.bmcl.2017.07.078 |
| Homo sapiens |
MCF7 |
IC50 |
12250.0 |
nM |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
MCF7 |
IC50 |
14100.0 |
nM |
10.1016/j.bmcl.2021.128146 |
| Homo sapiens |
MCF7 |
IC50 |
17403.0 |
nM |
10.1016/j.bmc.2007.10.046 |
| Homo sapiens |
MCF7 |
IC50 |
26330.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
38100.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
39200.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
IC50 |
42400.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
MCF7 |
Inhibition |
93.6 |
% |
10.1021/acs.jnatprod.6b00783 |
| Homo sapiens |
MDA-MB-231 |
Activity |
2.0 |
mm3 |
10.1016/j.bmc.2008.06.046 |
| Homo sapiens |
MDA-MB-231 |
Activity |
19.0 |
mm3 |
10.1016/j.bmc.2008.06.046 |
| Homo sapiens |
MDA-MB-231 |
Activity |
63.0 |
mm3 |
10.1016/j.bmc.2008.06.046 |
| Homo sapiens |
MDA-MB-231 |
Activity |
75.0 |
mm3 |
10.1016/j.bmc.2008.06.046 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
9170.0 |
nM |
10.1016/j.bmc.2011.10.014 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
14282.0 |
nM |
10.1016/j.ejmech.2019.111971 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
15560.0 |
nM |
10.1016/j.bmcl.2017.07.078 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
15600.0 |
nM |
10.1016/j.bmcl.2017.02.066 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
15600.0 |
nM |
10.1016/j.bmcl.2017.09.012 |
| Homo sapiens |
MDA-MB-435 |
Activity |
100.0 |
mm3 |
10.1021/jm1000612 |
| Homo sapiens |
MDA-MB-435 |
GI50 |
12200.0 |
nM |
10.1021/jm300605m |
| Homo sapiens |
MDA-MB-435 |
IC50 |
1140.0 |
nM |
10.1016/j.bmc.2010.03.039 |
| Homo sapiens |
MDA-MB-435 |
IC50 |
6300.0 |
nM |
10.1021/acs.jmedchem.5b00910 |
| Homo sapiens |
MDA-MB-435 |
IC50 |
17000.0 |
nM |
10.1021/jm100387d |
| Homo sapiens |
MDA-MB-435 |
T/C |
6.1 |
% |
10.1021/jm1000612 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
MG-63 |
IC50 |
18090.0 |
nM |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
MIA PaCa-2 |
IC50 |
1329.0 |
nM |
10.1021/acs.jmedchem.0c00305 |
| Homo sapiens |
MM473 |
Inhibition |
37.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
MRC5 |
GI50 |
77530.0 |
nM |
10.1016/j.bmc.2009.09.021 |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
2100.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
4300.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
7900.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
Inhibition |
49.0 |
% |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 2 |
IC50 |
7900.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 2 |
IC50 |
78600.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
1556.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
217.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NB-4 |
IC50 |
1000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
NCI/ADR-RES |
ID50 |
500.0 |
nM |
10.1016/s0960-894x(02)00153-1 |
| Homo sapiens |
NCI-H1299 |
CI |
0.25 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
CI |
0.66 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
CI |
1.04 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
CI |
1.1 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
CI |
1.13 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
CI |
nan |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
220.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
270.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
1670.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
1830.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
9830.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
11120.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
13130.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
15220.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
NCI-H1299 |
IC50 |
nan |
None |
10.1016/j.bmc.2021.116360 |
| Homo sapiens |
NCI-H1299 |
TGI |
67.0 |
% |
10.1021/ml5002745 |
| Homo sapiens |
NCI-H1299 |
TGI |
83.0 |
% |
10.1021/ml5002745 |
| Homo sapiens |
NCI-H1417 |
IC50 |
9790.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H146 |
IC50 |
11510.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H1650 |
IC50 |
39670.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H1975 |
IC50 |
21490.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H211 |
IC50 |
2810.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H2170 |
IC50 |
18810.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H226 |
IC50 |
4250.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H446 |
Activity |
2.28 |
g |
10.1016/j.ejmech.2022.114610 |
| Homo sapiens |
NCI-H446 |
IC50 |
0.01 |
nM |
10.1016/j.ejmech.2022.114610 |
| Homo sapiens |
NCI-H446 |
IC50 |
0.13 |
nM |
10.1016/j.ejmech.2022.114610 |
| Homo sapiens |
NCI-H446 |
IC50 |
0.15 |
nM |
10.1016/j.ejmech.2022.114610 |
| Homo sapiens |
NCI-H446 |
TGI |
26.79 |
% |
10.1016/j.ejmech.2022.114610 |
| Homo sapiens |
NCI-H460 |
IC50 |
15.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
NCI-H460 |
IC50 |
27.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
NCI-H460 |
IC50 |
2400.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
NCI-H460 |
IC50 |
5150.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H460 |
Ratio |
2.0 |
None |
10.1021/jm101354u |
| Homo sapiens |
NCI-H520 |
IC50 |
36160.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H526 |
Activity |
nan |
None |
10.1016/j.ejmech.2016.12.046 |
| Homo sapiens |
NCI-H526 |
IC50 |
490.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
NCI-H69 |
IC50 |
22.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
NCI-H82 |
IC50 |
2260.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
OCI-Ly3 |
Activity |
0.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
OCI-Ly3 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
Ovarian cancer cell line |
IC50 |
75300.0 |
nM |
10.1021/acs.jmedchem.2c00573 |
| Homo sapiens |
OVCAR-3 |
Activity |
38.53 |
mm3/day |
None |
| Homo sapiens |
PC-3 |
IC50 |
4.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
PC-3 |
IC50 |
nan |
None |
10.1016/j.bmc.2021.116360 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
RKO |
IC50 |
700.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
RKO |
IC50 |
6200.0 |
nM |
10.1021/acs.jnatprod.5b00743 |
| Homo sapiens |
RPMI 8402 |
IC50 |
570.0 |
nM |
10.1021/jm020498a |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SJSA-1 |
Inhibition |
0.0002 |
% |
10.1021/jm901400z |
| Homo sapiens |
SK-MEL-2 |
IC50 |
100.0 |
nM |
10.1021/jm101354u |
| Homo sapiens |
SK-OV-3 |
Activity |
2.9 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
3.72 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
5.78 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
6.24 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
21.58 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
30.01 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
51.2 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
66.27 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
80.86 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
81.99 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
85.03 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Activity |
nan |
None |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
IC50 |
13630.0 |
nM |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
SK-OV-3 |
Inhibition |
53.5 |
% |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
20800.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 2 |
IC50 |
2700.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 3 |
IC50 |
74600.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
60.0 |
% |
10.1124/dmd.104.001909 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
60.0 |
% |
10.1124/dmd.32.3.291 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
93.3 |
% |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
nan |
None |
10.1124/dmd.104.001909 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
nan |
None |
10.1124/dmd.32.3.291 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
40.5 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
26.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
34.3 |
% |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
16.3 |
% |
10.1021/jm300212s |
| Homo sapiens |
SW1990 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2020.112509 |
| Homo sapiens |
SW480 |
Activity |
0.871 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
SW480 |
Activity |
3.45 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
SW480 |
Activity |
10.7 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
SW480 |
Activity |
74.5 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
SW480 |
Activity |
85.0 |
% |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
SW480 |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
0.22 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
0.25 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
1.02 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
1.6 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
2.4 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
3.2 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
3.4 |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
CI |
nan |
None |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
IC50 |
70.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
IC50 |
120.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
IC50 |
600.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
IC50 |
1400.0 |
nM |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
SW480 |
IC50 |
1400.0 |
nM |
10.1021/acs.jnatprod.5b00877 |
| Homo sapiens |
SW480 |
IC50 |
1400.0 |
nM |
10.1021/acs.jnatprod.9b00580 |
| Homo sapiens |
SW480 |
IC50 |
3800.0 |
nM |
10.1021/acs.jnatprod.2c00224 |
| Homo sapiens |
SW480 |
IC50 |
7200.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
IC50 |
11170.0 |
nM |
10.1016/j.bmcl.2023.129128 |
| Homo sapiens |
SW480 |
IC50 |
12300.0 |
nM |
10.1021/acs.jnatprod.5b00743 |
| Homo sapiens |
SW480 |
IC50 |
12400.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
IC50 |
15400.0 |
nM |
10.1016/j.ejmech.2022.114196 |
| Homo sapiens |
SW480 |
Inhibition |
95.0 |
% |
10.1021/acs.jnatprod.6b00783 |
| Homo sapiens |
SW-620 |
Activity |
0.34 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
4.12 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
5.3 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
7.84 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
13.18 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
33.53 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
55.12 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
81.18 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
87.7 |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Activity |
nan |
None |
10.1021/jm2007326 |
| Homo sapiens |
SW-620 |
IC50 |
5.1 |
nM |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
Inhibition |
nan |
% |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
SW-620 |
TGI |
74.0 |
% |
10.1021/acsmedchemlett.8b00200 |
| Homo sapiens |
SW-620 |
TGI |
nan |
None |
10.1021/acs.jmedchem.6b00519 |
| Homo sapiens |
T-24 |
Inhibition |
23.8 |
% |
10.1016/j.ejmech.2008.01.008 |
| Homo sapiens |
T47D |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111990 |
| Homo sapiens |
T84 |
Efficacy |
82.0 |
% |
10.1021/acs.jnatprod.5b00072 |
| Homo sapiens |
T84 |
IC50 |
6.9 |
nM |
10.1016/j.bmc.2020.115849 |
| Homo sapiens |
T84 |
IC50 |
1200.0 |
nM |
10.1021/acs.jnatprod.5b00072 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
1778.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
U-251 |
IC50 |
nan |
None |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
U-251 |
IC50 |
nan |
None |
10.1021/acs.jnatprod.9b00580 |
| Homo sapiens |
U2932 |
IC50 |
4400.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| Homo sapiens |
U2OS |
IC50 |
14210.0 |
nM |
10.1016/j.ejmech.2020.112067 |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
WiDr |
IC50 |
13900.0 |
nM |
10.1016/j.bmc.2021.116360 |
| Homo sapiens |
ZR-75-30 |
IC50 |
18000.0 |
nM |
10.1016/j.bmcl.2017.03.039 |
| Mus musculus |
Colon 26 |
Activity |
nan |
None |
10.1016/j.bmc.2018.11.037 |
| Mus musculus |
L1210 |
IC50 |
1200.0 |
nM |
10.1021/jm00105a017 |
| Mus musculus |
Mus musculus |
Activity |
3.66 |
g |
10.1016/j.ejmech.2016.03.029 |
| Mus musculus |
Mus musculus |
Activity |
8.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| Mus musculus |
Mus musculus |
Activity |
12.7 |
% |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
18.4 |
g |
10.1021/jm1000612 |
| Mus musculus |
Mus musculus |
Activity |
19.5 |
g |
10.1021/jm1000612 |
| Mus musculus |
Mus musculus |
Activity |
19.8 |
g |
10.1021/jm1000612 |
| Mus musculus |
Mus musculus |
Activity |
19.9 |
g |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
20.5 |
g |
10.1016/j.ejmech.2016.11.013 |
| Mus musculus |
Mus musculus |
Activity |
20.7 |
g |
10.1021/jm1000612 |
| Mus musculus |
Mus musculus |
Activity |
20.8 |
g |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
21.3 |
g |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
21.6 |
g |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
22.3 |
g |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
22.4 |
g |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
147.0 |
g |
10.1016/j.ejmech.2016.11.013 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2015.03.031 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.ejmech.2016.11.013 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.ejmech.2018.07.028 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm300969t |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm3012933 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm301788a |
| Mus musculus |
Mus musculus |
Antitumor activity |
1.16 |
g |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Antitumor activity |
1.24 |
g |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Antitumor activity |
1.31 |
g |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Antitumor activity |
49.5 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
BWC |
-28.0 |
% |
10.1016/j.bmcl.2005.04.063 |
| Mus musculus |
Mus musculus |
Cures |
0.0 |
None |
10.1021/jm020420u |
| Mus musculus |
Mus musculus |
Growth delay |
7.0 |
day |
10.1021/jm020420u |
| Mus musculus |
Mus musculus |
ILS |
138.0 |
% |
10.1021/jm00105a017 |
| Mus musculus |
Mus musculus |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c00305 |
| Mus musculus |
Mus musculus |
Inhibition rate |
46.6 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Inhibition rate |
52.7 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
LD50 |
177.5 |
mg.kg-1 |
10.1021/jm5003588 |
| Mus musculus |
Mus musculus |
%max |
-3.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| Mus musculus |
Mus musculus |
%max |
0.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| Mus musculus |
Mus musculus |
MTD |
100.0 |
mg kg-1 |
10.1016/j.bmcl.2009.02.031 |
| Mus musculus |
Mus musculus |
MTD |
100.0 |
mg kg-1 |
10.1016/j.bmcl.2009.03.123 |
| Mus musculus |
Mus musculus |
MTD |
200.0 |
mg kg-1 |
10.1016/s0960-894x(02)00153-1 |
| Mus musculus |
Mus musculus |
MTD |
245.0 |
uM kg-1 |
10.1021/jm00105a017 |
| Mus musculus |
Mus musculus |
Survival time |
12.5 |
day |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Survival time |
13.2 |
day |
10.1016/j.bmcl.2003.12.098 |
| Mus musculus |
Mus musculus |
Survival time |
13.2 |
day |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Survival time |
14.5 |
day |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Survival time |
14.7 |
day |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Survival time |
15.7 |
day |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
Survival time |
17.5 |
day |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
T/C |
129.0 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
T/C |
152.0 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
T/C |
162.0 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
T/C |
172.0 |
% |
10.1016/j.bmcl.2003.12.098 |
| Mus musculus |
Mus musculus |
T/C |
172.0 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
T/C |
189.0 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
T/C |
217.0 |
% |
10.1016/s0960-894x(02)00153-1 |
| Mus musculus |
Mus musculus |
T/C |
228.0 |
% |
10.1021/jm031072e |
| Mus musculus |
Mus musculus |
TW |
0.01 |
None |
10.1016/j.bmcl.2005.04.063 |
| Mus musculus |
Mus musculus |
TWI |
99.4 |
% |
10.1016/j.bmcl.2005.04.063 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P-glycoprotein 1 and 3 (MDR1a/MDR1b) |
Activity |
nan |
None |
10.1007/s00280-001-0420-4 |
| Mus musculus |
P-glycoprotein 3 |
Activity |
nan |
None |
10.1023/a:1023847521767 |
| Oryctolagus cuniculus |
Acyl coenzyme A:cholesterol acyltransferase |
Activity |
2.147 |
nM/mg*min |
10.1016/s0960-894x(98)00039-0 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver carboxylesterase 3 |
Activity |
0.259 |
nM/mg*min |
10.1016/s0960-894x(98)00039-0 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Plasma |
T1/2 |
0.75 |
hr |
10.1016/j.bmcl.2012.07.061 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
299.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
330.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
334.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
367.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
402.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
415.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
38.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
45.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
45.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
49.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
54.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
56.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
79.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
85.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
93.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
93.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
100.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
101.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
146.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
156.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
163.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
180.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
213.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
96.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.17 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
650.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
686.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
703.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
735.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
763.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
268.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
339.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
421.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
434.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
578.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
991.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
22670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25500000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26500000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.1 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.4 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
16.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
23.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
58.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
80.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
215.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
2.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1488.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1510.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1526.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1551.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1570.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1716.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.85 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.93 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.13 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.68 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.73 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.73 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
137200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
139000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
142300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
143000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
146000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
151000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
294.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
382.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
395.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
435.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
530.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
603.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
8779.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
9024.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
10356.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
10653.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12448.83 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15491.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
86.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
87.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
87.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
91.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
95.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.93 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.0 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.73 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.85 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.67 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.73 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
387700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
393800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
395700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
397700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
398000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
400700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.7 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.5 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.47 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.73 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
64.7 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
65.2 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
17.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
74.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
116.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
139.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
259.5 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
4.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
11.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
11.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
470.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
658.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
746.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
933.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1635.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
2000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
126.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
129.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
134.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
135.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
143.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
150.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1185670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1219500.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1232330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1248670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1288000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1386670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.54 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.6 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.66 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.68 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.75 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
59300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
59700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
59800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
66700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5350000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5400000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5760000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5880000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5970000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6320000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
139.78 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
142.97 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.87 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
145.83 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.17 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
15.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
20.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
28.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9930.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
10070.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
10900.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
11430.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14370.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
17670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
25118.9 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
56234.1 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
121.15 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.01 |
% |
10.6019/CHEMBL4495565 |
| Torpedo californica |
Acetylcholinesterase |
Ki |
26.4 |
nM |
10.1021/jm701253t |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmcl.2023.129128 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2020.112067 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00305 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jnatprod.2c00224 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jnatprod.2c00832 |
| None |
ADMET |
CL |
3.0 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
3.9 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
7.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
7.4 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
11.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
13.49 |
mL.min-1.g-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
37.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Drugexcretion |
37.0 |
% |
10.1016/j.bmcl.2016.12.085 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.0c00305 |
| None |
ADMET |
Drug uptake |
nan |
None |
10.1021/acs.jmedchem.0c00305 |
| None |
ADMET |
IC50 |
1.0 |
nM |
10.1021/jm101354u |
| None |
ADMET |
IC50 |
110.0 |
nM |
10.1021/jm101354u |
| None |
ADMET |
IC90 |
800.0 |
nM |
10.1021/jm101354u |
| None |
ADMET |
LD50 |
85.1 |
mg.kg-1 |
10.1016/j.ejmech.2020.112509 |
| None |
ADMET |
MRT |
8.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
No. of mice dead |
0.0 |
None |
10.1016/j.bmcl.2005.04.063 |
| None |
ADMET |
Papp |
1.4 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
1.5 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
2.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
3.9 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
4.1 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
5.1 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
PPB |
57.99 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio |
1.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
2.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
3.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
21.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
23.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
29.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
38.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
54.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
66.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
85.0 |
None |
10.1021/jm101354u |
| None |
ADMET |
Ratio |
100.0 |
None |
10.1021/jm101354u |
| None |
ADMET |
Ratio IC50 |
1.39 |
None |
10.1016/j.bmcl.2023.129128 |
| None |
ADMET |
Ratio IC50 |
1.56 |
None |
10.1016/j.bmcl.2023.129128 |
| None |
ADMET |
T1/2 |
9.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
56.8 |
hr |
10.1016/j.ejmech.2022.114304 |
| None |
ADMET |
Vdss |
1.0 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
2.1 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
3.2 |
mL/min/kg |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
3.5 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
3.8 |
L.kg-1 |
10.1002/jps.20373 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
4.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
2.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
2.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
4.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
6.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
6.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Mononuclear cell line |
IC50 |
25400.0 |
nM |
10.1021/acs.jmedchem.2c00573 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
Efficacy |
76.0 |
% |
10.1021/acs.jnatprod.5b00072 |
| None |
NON-PROTEIN TARGET |
Fu |
0.51 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
GI50 |
4730.0 |
nM |
10.1016/j.bmc.2009.09.021 |
| None |
NON-PROTEIN TARGET |
GI50 |
4730.0 |
nM |
10.1016/j.bmc.2011.10.014 |
| None |
NON-PROTEIN TARGET |
GI50 |
10000.0 |
nM |
10.1016/j.bmc.2009.09.021 |
| None |
NON-PROTEIN TARGET |
GI50 |
10000.0 |
nM |
10.1016/j.bmc.2011.10.014 |
| None |
NON-PROTEIN TARGET |
GI50 |
14125.38 |
nM |
10.1016/j.bmcl.2010.10.004 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
4.2 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
12.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
13.3 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
10.0 |
nM |
10.1021/jm101354u |
| None |
NON-PROTEIN TARGET |
IC50 |
22.0 |
nM |
10.1021/jm101354u |
| None |
NON-PROTEIN TARGET |
IC50 |
680.0 |
nM |
10.1016/j.bmc.2008.08.018 |
| None |
NON-PROTEIN TARGET |
IC50 |
800.0 |
nM |
10.1021/acs.jnatprod.5b00072 |
| None |
NON-PROTEIN TARGET |
IC50 |
2000.0 |
nM |
10.1021/acs.jnatprod.5b00743 |
| None |
NON-PROTEIN TARGET |
IC50 |
7400.0 |
nM |
10.1016/j.bmc.2008.08.018 |
| None |
NON-PROTEIN TARGET |
IC50 |
7530.0 |
nM |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
IC50 |
8500.0 |
nM |
10.1021/acs.jnatprod.5b00743 |
| None |
NON-PROTEIN TARGET |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2012.10.002 |
| None |
NON-PROTEIN TARGET |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2016.02.070 |
| None |
NON-PROTEIN TARGET |
IC50 |
20000.0 |
nM |
10.1021/jm5003588 |
| None |
NON-PROTEIN TARGET |
IC50 |
25100.0 |
nM |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
IC50 |
40000.0 |
nM |
10.1016/j.bmc.2008.08.018 |
| None |
NON-PROTEIN TARGET |
IC50 |
100000.0 |
nM |
10.1021/jm020498a |
| None |
NON-PROTEIN TARGET |
IC50 |
250000.0 |
nM |
10.1039/C4MD00264D |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
None |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1021/jm5003588 |
| None |
NON-PROTEIN TARGET |
LC50 |
95499.26 |
nM |
10.1016/j.bmcl.2010.10.004 |
| None |
NON-PROTEIN TARGET |
%max |
90.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
%max |
92.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
TGI |
32.7 |
% |
None |
| None |
NON-PROTEIN TARGET |
TGI |
68.6 |
% |
10.1021/acs.jnatprod.5b00743 |
| None |
NON-PROTEIN TARGET |
TGI |
70.2 |
% |
10.1016/j.ejmech.2016.03.029 |
| None |
NON-PROTEIN TARGET |
TGI |
78.0 |
% |
None |
| None |
NON-PROTEIN TARGET |
TGI |
85.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| None |
NON-PROTEIN TARGET |
TGI |
90.0 |
% |
10.1016/j.ejmech.2014.02.018 |
| None |
No relevant target |
LogP |
3.2 |
None |
10.1016/j.ejmech.2009.12.043 |
| None |
No relevant target |
pKa |
10.9 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
Solubility |
597.4 |
ug.mL-1 |
10.1016/j.bmcl.2023.129128 |
| None |
No relevant target |
Solubility |
1203.0 |
ug.mL-1 |
10.1016/j.bmcl.2023.129128 |
| None |
No relevant target |
Solubility |
5594.0 |
ug.mL-1 |
10.1016/j.bmcl.2023.129128 |
| None |
Unchecked |
Activity |
36.0 |
% |
10.1016/j.ejmech.2017.11.021 |
| None |
Unchecked |
Hepatotoxicity (acute) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
740.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| None |
Unchecked |
IC50 |
9400.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| None |
Unchecked |
IC50 |
10376.3 |
nM |
10.1016/j.ejmech.2019.111971 |
| None |
Unchecked |
IC50 |
14980.0 |
nM |
10.1021/acs.jmedchem.0c01733 |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2017.02.066 |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2017.07.078 |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2017.09.012 |
| None |
Unchecked |
IC50 |
20100.0 |
nM |
10.1016/j.ejmech.2017.11.021 |
| None |
Unchecked |
IC50 |
26550.0 |
nM |
10.1016/j.ejmech.2020.112067 |
| None |
Unchecked |
IC50 |
29300.0 |
nM |
10.1021/acs.jmedchem.2c00573 |
| None |
Unchecked |
IC50 |
89600.0 |
nM |
10.1021/acs.jmedchem.2c00573 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Ratio |
0.29 |
None |
10.1021/jm301302s |
| None |
Unchecked |
Ratio |
0.54 |
None |
10.1021/jm301302s |
| None |
Unchecked |
Ratio |
1.1 |
None |
10.1021/jm301302s |
| None |
Unchecked |
Ratio |
2.0 |
None |
10.1021/jm101354u |
| None |
Unchecked |
Ratio |
11.0 |
None |
10.1021/jm101354u |
| None |
Unchecked |
Ratio IC50 |
1.78 |
None |
10.1016/j.bmcl.2023.129128 |
| None |
Unchecked |
Ratio IC50 |
1.99 |
None |
10.1016/j.bmcl.2023.129128 |
| None |
Unchecked |
Ratio IC50 |
5.3 |
None |
10.1016/j.ejmech.2017.11.021 |
| None |
Unchecked |
Ratio IC50 |
13.0 |
None |
10.1016/j.ejmech.2022.114610 |
| None |
Unchecked |
Ratio IC50 |
15.0 |
None |
10.1016/j.ejmech.2022.114610 |
| None |
Unchecked |
Survival |
10.3 |
months |
10.1021/np030498t |